STAAR Surgical (STAA)
16.80
-0.97 (-5.46%)
At close: Feb 20, 2025, 3:59 PM
16.82
0.09%
After-hours: Feb 20, 2025, 05:34 PM EST
undefined% (undefined)
| Bid | 16.82 |
| Market Cap | 828.08M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.41 |
| PE Ratio (ttm) | -40.99 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 17.8 |
| Volume | 1,257,238 |
| Avg. Volume (20D) | 825,849 |
| Open | 17.71 |
| Previous Close | 17.77 |
| Day's Range | 16.78 - 18.09 |
| 52-Week Range | 13.50 - 52.68 |
| Beta | undefined |
About STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone c...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Feb 24, 1992
Employees 1,056
Stock Exchange NASDAQ
Ticker Symbol STAA
Website https://www.staar.com
Analyst Forecast
According to 9 analyst ratings, the average rating for STAA stock is "Hold." The 12-month stock price forecast is $28, which is an increase of 66.62% from the latest price.
Buy 33.33%
Hold 55.56%
Sell 11.11%
Next Earnings Release
STAAR Surgical is scheduled to release its earnings on May 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-24.68%
Staar Surgical shares are trading lower after the ...
Unlock content with
Pro Subscription
1 week ago
-3.23%
Staar Surgical shares are trading lower after the company reported worse-than-expected Q4 financial results.
